First Time Loading...

Microbot Medical Inc
NASDAQ:MBOT

Watchlist Manager
Microbot Medical Inc Logo
Microbot Medical Inc
NASDAQ:MBOT
Watchlist
Price: 0.891 USD 1.26%
Updated: Apr 25, 2024

Intrinsic Value

MBOT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. [ Read More ]

The intrinsic value of one MBOT stock under the Base Case scenario is 0.443 USD. Compared to the current market price of 0.891 USD, Microbot Medical Inc is Overvalued by 50%.

Key Points:
MBOT Intrinsic Value
Base Case
0.443 USD
Overvaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Microbot Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MBOT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Microbot Medical Inc

Provide an overview of the primary business activities
of Microbot Medical Inc.

What unique competitive advantages
does Microbot Medical Inc hold over its rivals?

What risks and challenges
does Microbot Medical Inc face in the near future?

Has there been any significant insider trading activity
in Microbot Medical Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Microbot Medical Inc.

Provide P/S
for Microbot Medical Inc.

Provide P/E
for Microbot Medical Inc.

Provide P/OCF
for Microbot Medical Inc.

Provide P/FCFE
for Microbot Medical Inc.

Provide P/B
for Microbot Medical Inc.

Provide EV/S
for Microbot Medical Inc.

Provide EV/GP
for Microbot Medical Inc.

Provide EV/EBITDA
for Microbot Medical Inc.

Provide EV/EBIT
for Microbot Medical Inc.

Provide EV/OCF
for Microbot Medical Inc.

Provide EV/FCFF
for Microbot Medical Inc.

Provide EV/IC
for Microbot Medical Inc.

Show me price targets
for Microbot Medical Inc made by professional analysts.

What are the Revenue projections
for Microbot Medical Inc?

How accurate were the past Revenue estimates
for Microbot Medical Inc?

What are the Net Income projections
for Microbot Medical Inc?

How accurate were the past Net Income estimates
for Microbot Medical Inc?

What are the EPS projections
for Microbot Medical Inc?

How accurate were the past EPS estimates
for Microbot Medical Inc?

What are the EBIT projections
for Microbot Medical Inc?

How accurate were the past EBIT estimates
for Microbot Medical Inc?

Compare the revenue forecasts
for Microbot Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Microbot Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Microbot Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Microbot Medical Inc compared to its peers.

Compare the P/E ratios
of Microbot Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Microbot Medical Inc with its peers.

Analyze the financial leverage
of Microbot Medical Inc compared to its main competitors.

Show all profitability ratios
for Microbot Medical Inc.

Provide ROE
for Microbot Medical Inc.

Provide ROA
for Microbot Medical Inc.

Provide ROIC
for Microbot Medical Inc.

Provide ROCE
for Microbot Medical Inc.

Provide Gross Margin
for Microbot Medical Inc.

Provide Operating Margin
for Microbot Medical Inc.

Provide Net Margin
for Microbot Medical Inc.

Provide FCF Margin
for Microbot Medical Inc.

Show all solvency ratios
for Microbot Medical Inc.

Provide D/E Ratio
for Microbot Medical Inc.

Provide D/A Ratio
for Microbot Medical Inc.

Provide Interest Coverage Ratio
for Microbot Medical Inc.

Provide Altman Z-Score Ratio
for Microbot Medical Inc.

Provide Quick Ratio
for Microbot Medical Inc.

Provide Current Ratio
for Microbot Medical Inc.

Provide Cash Ratio
for Microbot Medical Inc.

What is the historical Revenue growth
over the last 5 years for Microbot Medical Inc?

What is the historical Net Income growth
over the last 5 years for Microbot Medical Inc?

What is the current Free Cash Flow
of Microbot Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Microbot Medical Inc.

Financials

Balance Sheet Decomposition
Microbot Medical Inc

Current Assets 7.9m
Cash & Short-Term Investments 6.4m
Other Current Assets 1.5m
Non-Current Assets 406k
PP&E 406k
Current Liabilities 3.8m
Accounts Payable 357k
Accrued Liabilities 3.4m
Non-Current Liabilities 40k
Other Non-Current Liabilities 40k
Efficiency

Earnings Waterfall
Microbot Medical Inc

Revenue
0 USD
Operating Expenses
-9.9m USD
Operating Income
-9.9m USD
Other Expenses
-885k USD
Net Income
-10.7m USD

Free Cash Flow Analysis
Microbot Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MBOT Profitability Score
Profitability Due Diligence

Microbot Medical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Microbot Medical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

MBOT Solvency Score
Solvency Due Diligence

Microbot Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
52/100
Solvency
Score

Microbot Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MBOT Price Targets Summary
Microbot Medical Inc

There are no price targets for MBOT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

MBOT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

MBOT Price
Microbot Medical Inc

1M 1M
-24%
6M 6M
-26%
1Y 1Y
-41%
3Y 3Y
-88%
5Y 5Y
-89%
10Y 10Y
-100%
Annual Price Range
0.891
52w Low
0.865
52w High
3.45
Price Metrics
Average Annual Return -12.54%
Standard Deviation of Annual Returns 39.95%
Max Drawdown -95%
Shares Statistics
Market Capitalization 12.8m USD
Shares Outstanding 14 399 000
Percentage of Shares Shorted 1.36%

MBOT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Microbot Medical Inc Logo
Microbot Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

12.8m USD

Dividend Yield

0%

Description

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 17 full-time employees. The company specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include ViRob, TipCAT, LIBERTY and certain CardioSert assets. The ViRob is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The TipCAT is a disposable self-propelled locomotive device that is specially designed to advance tubular anatomy. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature. The company is developing Self-Cleaning Shunt (SCSTM), for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) using ViRob platform. The company is developing the fully disposable robot for various endovascular interventional procedures using LIBERTY and CardioSert platforms. The company is also focused on the development of a multi generation pipeline portfolio.

Contact

MASSACHUSETTS
Hingham
25 Recreation Park Dr Suite 108
+19089385561.0
http://www.microbotmedical.com/

IPO

1992-03-25

Employees

17

Officers

Co-Founder, President, CEO & Chairman
Mr. Harel Gadot
Co-Founder & Independent Director
Mr. Yoseph Bornstein
Chief Financial Officer
Ms. Rachel Vaknin
CTO & GM of Microbot Israel
Dr. Simon Sharon MBA, MSc
Chief Medical Officer
Dr. Juan Diaz-Cartelle

See Also

Discover More
What is the Intrinsic Value of one MBOT stock?

The intrinsic value of one MBOT stock under the Base Case scenario is 0.443 USD.

Is MBOT stock undervalued or overvalued?

Compared to the current market price of 0.891 USD, Microbot Medical Inc is Overvalued by 50%.